06660.HK_Providing professional financial news and data related to 06660.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

AIM Vaccine (06660.HK): Serum-Free Iterative Rabies Vaccine Completes Supplementary Data Submission for Registration; NDA Achieves Key Milestone

Tags：

AIM VACCINE 06660.HK

2026-08-03

AIM VACCINE(06660.HK) closed 21.83% higher, the latest market capitalization at HKD 1.56 billion

Tags：

AIM VACCINE 06660.HK

2026-05-08

ETF
Premia China STAR50 ETF (03151.HK) Rises 2.88% in Morning Trade, Turnover at HKD 3.3823 Million
ETF
Chinaamc CSI 300 Index ETF (03188.HK) Rises 1.54% in Morning Trade, Latest Price at HKD 56.680
Finance
JIANGSU NEW VISION AUTOMOTIVE ELECTRONICS (02632.HK): Expected First-Half Pretax Loss of Approximately RMB 402 Million to 422 Million
Finance
China Ruyi (00136.HK): Expected First-Half Net Profit of Approximately RMB 800 Million to 900 Million
Finance
SenseTime-W (00020.HK): Expected First-Half Profit of Approximately RMB 500 Million to 700 Million
Finance
CanSino Biologics (06185.HK): NDA for Td5cp, a Diphtheria-Tetanus-Pertussis Vaccine for Adolescents and Adults, Accepted for Review
Finance
160 Health International Limited (02656.HK): Expected Turnaround to Profit in First Half, Net Profit of Approximately RMB 1 Million to 3 Million
Research
HK shares Newly Listed Stocks Tracking Weekly Report: No Lock-up Expiries Next Week; INNOGEN-B and HAIZHI TECH GP Both Down Over 13% for the Week - 20260814
Finance
CENTRAL CHINA MANAGEMENT COMPANY (09982.HK): Completion of Allotment and Issuance of 773 Million Subscription Shares
Finance
MemeStrategy, Inc. (02440.HK): Executive Director and Chief Investment Officer Li Minghong Resigns

Scan QR Code

Download App